Westpac Banking Corp’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.65M Sell
11,922
-330
-3% -$140K 0.29% 86
2026
Q1
$5.8M Hold
12,252
0.4% 57
2025
Q4
$5.72M Buy
12,252
+11,849
+2,940% +$5.5M 0.36% 64
2025
Q3
$172K Sell
403
-10,289
-96% -$3.99M 0.01% 362
2025
Q2
$4.1M Sell
10,692
-13,430
-56% -$4.84M 0.27% 92
2025
Q1
$8.34M Sell
24,122
-584
-2% -$188K 0.61% 35
2024
Q4
$7.42M Buy
24,706
+1,302
+6% +$455K 0.49% 41
2024
Q3
$9.51M Sell
23,404
-6,916
-23% -$2.53M 0.64% 33
2024
Q2
$9.74M Buy
30,320
+7,850
+35% +$2.55M 0.77% 25
2024
Q1
$7.49M Sell
22,470
-12,133
-35% -$3.71M 0.57% 39
2023
Q4
$9.37M Buy
34,603
+8,332
+32% +$2.06M 0.77% 24
2023
Q3
$6.46M Sell
26,271
-4,491
-15% -$1.23M 0.48% 45
2023
Q2
$9.34M Sell
30,762
-70,645
-70% -$19.6M 0.66% 28
2023
Q1
$26.7M Sell
101,407
-16,864
-14% -$4.28M 0.36% 58
2022
Q4
$28.4M Sell
118,271
-7,081
-6% -$1.59M 0.42% 50
2022
Q3
$23M Sell
125,352
-20,144
-14% -$4.01M 0.35% 57
2022
Q2
$24.5M Buy
145,496
+2,514
+2% +$540K 0.32% 66
2022
Q1
$35.8M Buy
142,982
+29,298
+26% +$7.36M 0.41% 43
2021
Q4
$29.2M Sell
113,684
-11,169
-9% -$2.73M 0.3% 74
2021
Q3
$30.3M Sell
124,853
-15,149
-11% -$3.7M 0.32% 65
2021
Q2
$28.9M Buy
140,002
+671
+0.5% +$137K 0.29% 72
2021
Q1
$26.2M Buy
139,331
+6,037
+5% +$1.06M 0.29% 83
2020
Q4
$21.9M Buy
133,294
+36,225
+37% +$5.3M 0.25% 106
2020
Q3
$12.1M Buy
97,069
+5,144
+6% +$637K 0.16% 154
2020
Q2
$8.92M Sell
91,925
-192,221
-68% -$20M 0.13% 191
2020
Q1
$25.5M Buy
284,146
+6,506
+2% +$842K 0.44% 44
2019
Q4
$41M Sell
277,640
-76,167
-22% -$10.2M 0.53% 24
2019
Q3
$42.6M Buy
353,807
+400
+0.1% +$51.7K 0.59% 23
2019
Q2
$47.8M Buy
353,407
+41,250
+13% +$5.22M 0.73% 17
2019
Q1
$40.7M Buy
312,157
+23,437
+8% +$3.15M 0.67% 23
2018
Q4
$35.9M Buy
288,720
+188,453
+188% +$25.3M 0.61% 24
2018
Q3
$13.9M Buy
100,267
+81,168
+425% +$10.1M 0.24% 126
2018
Q2
$1.96M Hold
19,099
0.04% 398
2018
Q1
$1.85M Hold
19,099
0.04% 396
2017
Q4
$1.68M Hold
19,099
0.04% 388
2017
Q3
$1.52M Sell
19,099
-600
-3% -$48.3K 0.03% 435
2017
Q2
$1.72M Buy
19,699
+1,178
+6% +$99.7K 0.04% 419
2017
Q1
$1.65M Hold
18,521
0.01% 579
2016
Q4
$1.48M Hold
18,521
0.01% 519
2016
Q3
$1.4M Sell
18,521
-140,983
-88% -$10.8M 0.02% 511
2016
Q2
$11M Sell
159,504
-18,467
-10% -$1.46M 0.12% 195
2016
Q1
$13.9M Buy
177,971
+11,249
+7% +$786K 0.15% 144
2015
Q4
$11.3M Buy
166,722
+64,184
+63% +$4.48M 0.12% 185
2015
Q3
$7.93M Buy
102,538
+59,884
+140% +$5.3M 0.09% 219
2015
Q2
$3.87M Buy
42,654
+24,554
+136% +$1.97M 0.04% 344
2015
Q1
$1.52M Sell
18,100
-988
-5% -$71K 0.01% 542
2014
Q4
$1.4M Sell
19,088
-800
-4% -$56.2K 0.01% 554
2014
Q3
$1.4M Sell
19,888
-1,275
-6% -$84.3K 0.01% 550
2014
Q2
$1.19M Sell
21,163
-356
-2% -$18.8K 0.01% 577
2014
Q1
$1.13M Sell
21,519
-20,055
-48% -$998K 0.01% 549
2013
Q4
$1.98M Buy
41,574
+1,469
+4% +$67.9K 0.02% 486
2013
Q3
$1.71M Sell
40,105
-721
-2% -$28.2K 0.02% 474
2013
Q2
$1.61M Buy
+40,826
New +$1.58M 0.02% 449

Other funds holding HCA

Westpac Banking Corp's HCA Position: Q2 2026 in Review

Westpac Banking Corp reduced its HCA Healthcare (HCA) stake by 2.7% in Q2 2026, selling an estimated $140K and leaving 11,922 shares worth $4.65M. The position accounts for 0.29% of the portfolio, ranked #86.

Westpac Banking Corp first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $47.8M in Q2 2019. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Westpac Banking Corp held 11,922 shares of HCA Healthcare worth $4.65M as of Q2 2026.
  • Westpac Banking Corp sold 330 HCA Healthcare shares in Q2 2026, an estimated $140K.
  • HCA Healthcare made up 0.29% of Westpac Banking Corp's portfolio in Q2 2026, its #86 holding.
  • Westpac Banking Corp first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
  • Westpac Banking Corp's HCA Healthcare position peaked at $47.8M in Q2 2019.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Westpac Banking Corp's 13F filing for Q2 2026, filed 12 Aug 2026.